Overexpression of hAPPswe impairs rewarded alternation and contextual fear conditioning in a transgenic mouse model of Alzheimer's disease

Learning and Memory

Volumn 9, Issue 5, 2002, Pages 243-252

  Corcoran, Kevin A ^a   Lu, Ye ^b   Scott Turner, R ^b,c   Maren, Stephen ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN;

ALZHEIMER DISEASE; AMNESIA; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ARTICLE; AUDITORY STIMULATION; BRAIN CORTEX; CONDITIONING; CONTROLLED STUDY; FEAR; GENE OVEREXPRESSION; HIPPOCAMPUS; HISTOLOGY; LEARNING; LEARNING DISORDER; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; REWARD; TRANSGENIC MOUSE;

AGE FACTORS; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BEHAVIOR, ANIMAL; CONDITIONING, CLASSICAL; DISCRIMINATION LEARNING; DISEASE MODELS, ANIMAL; ELECTROSHOCK; FEAR; FEMALE; GENE EXPRESSION; HUMANS; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; REWARD;

EID: 0036743625     PISSN: 10720502     EISSN: None     Source Type: Journal    
DOI: 10.1101/lm.51002     Document Type: Article

References (63)

1. Antoniadis, E.A. and McDonald, R.J. 1999. Discriminative fear conditioning to context expressed by multiple measures of fear in the rat. Behav. Brain Res. 101: 1-13.
2. -, 2000. Amygdala, hippocampus and discriminative fear conditioning to context. Behav. Brain Res. 108: 1-19.
3. Ashe, K.H. 2001. Learning and memory in transgenic mice modeling Alzheimer's disease. Learn. Mem. 8: 301-308.
4. Bannerman, D.M., Yee, B.K., Lemaire, M., Wilbrecht, L., Jarrard, L., Iversen, S.D., Rawlins, J.N., and Good, M.A. 2001a. The role of the entorhinal cortex in two forms of spatial learning and memory. Exp. Brain Res. 141: 281-303.
5. Bannerman, D.M., Yee, B.K., Lemaire, M., Jarrard, L., Iversen, S.D., Rawlins, J.N., and Good, M.A. 2001b. Contextual fear conditioning is disrupted by lesions of the subcortical, but not entorhinal, connections to the hippocampus. Exp. Brain Res. 141: 304-311.
6. Braak, H. and Braak, E. 1991. Neuropathological staging of Alzheimer related changes. Acta Neuropathol. 82: 239-259.
7. Chapman, P.F., White, G.L., Jones, M.W., Cooper-Blacketer, D., Marshall, V.J., Irizarry, M., Younkin, L., Good, M.A., Bliss, T.V.P., Hyman, B.T., et al. 1999. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat. Neurosci. 2: 271-276.
8. Chapman, P.F., Falinska, A.M., Knevett, S.G., and Ramsay, M.F. 2001. Genes, models, and Alzheimer's disease. Trends Genet. 17: 254-261.
9. Dineley, K.T., Xia, X., Bui, D., Sweatt, J.D., and Zheng, H. 2002. Accelerated plaque accumulation, associative learning deficits and up-regulation of α7 nicotinic receptor protein in transgenic mice co-expressing mutant human presenilin 1 and amyloid precursor proteins. J. Biol. Chem. 277: 22768-22780.
10. Fitzjohn, S.M., Morton, R.A., Kuenzi, F., Rosahl, T.W., Shearman, M., Lewis, H., Smith, D., Reynolds, D.S., Davies, C.H., Collingridge, G.L., et al. 2001. Age-related impairment of synaptic transmission but normal long-term potentiation in transgenic mice that overexpress the human APP695SWE mutant form of amyloid precursor protein. J. Neurosci. 21: 4691-4698.
11. Frankland, P.W., Cestari, V., Filipkowski, R.K., McDonald, R.J., and Silva, A.J. 1998. The dorsal hippocampus is essential for context discrimination but not for contextual conditioning. Behav. Neurosci. 112: 863-874.
12. Frautschy, S.A., Yang, F., Irrizarry, M., Hyman, B., Saido, T.C., Hsiao, K., and Cole, G.M. 1998. Microglial response to amyloid plaques in APPsw transgenic mice. Am. J. Pathol. 152: 307-317.
13. Gau, J.-T., Steinhilb, M.L., Kao, T.-C., D'Amato, C.J., Gaut, J.R., Frey, K.A., and Turner, R.S. 2002. Stable β-secretase activity and presynaptic cholinergic markers during progressive CNS amyloidogenesis in Tg2576 mice. Am. J. Pathol. 160: 731-738.
14. Gómez-Isla, T., Price, J.L., McKeel Jr., D.W., Morris, J.C., Growdon, J.H., and Hyman, B.T. 1996. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J. Neurosci. 16: 4491-4500.
15. Good, M.A. and Honey, R.C. 1991. Conditioning and contextual retrieval in hippocampal rats. Behav. Neurosci. 105: 499-509.
16. Grady, C.L., Furey, M.L., Pietrini, P., Horwitz, B., and Rapoport, S.I. 2001. Altered brain functional connectivity and impaired short-term memory in Alzheimer's disease. Brain 124: 739-756.
17. Hamann, S.B., Monarch, E.S., and Goldstein, F.C. 2000. Memory enhancement for emotional stimuli is impaired in early Alzheimer's disease. Neuropsychology 14: 82-92.
18. -, 2002. Impaired fear conditioning in Alzheimer's disease. Neuropsychologia 40:1187-1195.
19. Hopper, M.W. and Vogel, F.S. 1976. The limbic system in Alzheimer's disease: A neuropathologic investigation. Am. J. Pathol. 85: 1-20.
20. Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., and Cole, G. 1996. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274: 99-102.
21. Hyman, B.T., Van Hoesen, G.W., Damasio, A.R., and Barnes, C.L. 1984. Alzheimer's disease: Cell specific pathology isolates the hippocampal formation in Alzheimer's disease. Science 225: 1168-1170.
22. Hyman, B.T., Van Hoesen, G.W., and Damasio, A.R. 1990. Memory-related systems in Alzheimer's disease: An anatomic study. Neurology 40: 1721-1730.
23. Irizarry, M.C. McNamara, M., Fedorchak, K., Hsiao K., and Hyman, B.T. 1997. APPSw transgenic mice develop age-related A β deposits and neuropil abnormalities, but no neuronal loss in CA1. J. Neuropathol. Exp. Neurol. 56: 965-973.
24. Kim, J.J. and Fanselow, M.S. 1992. Modality-specific retrograde amnesia of fear. Science 256: 675-677.
25. SW transgenic mouse model for Alzheimer's disease. Behav. Brain Res. 103: 145-162.
26. Lavenu, I., Pasquier, F., Lebert, F., Petit, H., and Van der Linden, M. 1999. Perception of emotion in frontotemporal dementia and Alzheimer disease. Alzheimer Dis. Assoc. Disord. 13: 96-101.
27. Maren, S. 1998. Overtraining does not mitigate contextual fear conditioning deficits produced by neurotoxic lesions of the basolateral amygdala. J. Neurosci. 18: 3088-3907.
28. -, 1999. Neurotoxic basolateral amygdala lesions impair learning and memory but not the performance of conditional fear in rats. J. Neurosci. 19: 8696-8703.
29. Maren, S. and Fanselow, M.S. 1996. The amygdala and fear conditioning: Has the nut been cracked? Neuron 16: 237-240.
30. Maren, S., Aharonov, G., and Fanselow, M.S. 1997. Neurotoxic lesions of the dorsal hippocampus and Pavlovian fear conditioning in rats. Behav. Brain Res. 88: 261-274.
31. Maren, S., Anagnostaras, S.G., and Fanselow, M.S. 1998. The startled seahorse: is the hippocampus necessary for contextual fear conditioning? Trends Cog. Sci. 2: 39-42.
32. Matsuoka, Y., Picciano, M., La Francois, J., and Duff. K. 2001. Fibrillar β-amyloid evokes oxidative damage in a transgenic mouse model of Alzheimer's disease. Neuroscience 104: 609-613.
33. Moayeri, S.E., Cahill, L., Jin, Y., and Potkin, S.G. 2000. Relative sparing of emotionally influenced memory in Alzheimer's disease. Neuroreport 11: 653-655.
34. Moran, P.M., Higgins, L.S., Cordell, B., and Moser, P.C. 1995. Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human β-amyloid precursor protein. Proc. Natl. Acad. Sci. 92: 5341-5345.
35. Morgan, D., Diamond, D.M., Gottschall, P.E., Ugen, K.E., Dickey, C., Hardy, J., Duff, K., Jantzen, P., DiCarlo, G., Wilcock, D., et al. 2000. Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 408: 982-985.
36. Mori, E., Yoneda, Y., Yamashita, H., Hirono, N., Ikeda, M., and Yamadori, A. 1997. Medial temporal structures relate to memory impairment in Alzheimer's disease: An MRI volumetric study. J. Neurol. Neurosurg. Psychiat. 63: 214-221.
37. Mori, E., Ikeda, M., Hirono, N., Kitagaki, H., Imamura, T., and Shimomura, T. 1999. Amygdalar volume and emotional memory in Alzheimer's disease. Am. J. Psychiatry 156: 216-222.
38. Nalbantoglu, J., Tirado-Santiago, G., Lahsaïni, A., Poirier, J., Goncalves, O., Verge, G., Momoli, F., Welner, S.A., Massicotte, G., Julien, J.-P., et al. 1997. Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein. Nature 387: 500-505.
39. Näslund, J., Haroutunian, V., Mohs, R., Davis, K.L., Davies, P., Greengard, P., and Buxbaum, J.D. 2000. Correlation between elevated levels of amyloid β-peptide in the brain and cognitive decline. J. Am. Med. Assoc 283: 1571-1577.
40. Odling-Smee, F.J. 1978. The overshadowing of background stimuli by an informative VS in aversive Pavlovian conditioning with rats. Anim. Learn. Behav. 6: 43-51.
41. Pappolla, M.A., Chyan, Y.J., Omar, R.A., Hsiao, K., Perry, G., Smith, M.A., and Bozner, P. 1998. Evidence of oxidative stress and in vivo neurotoxicity of β-amyloid in a transgenic mouse model of Alzheimer's disease: A chronic oxidative paradigm for testing antioxidant therapies in vivo. Am. J. Pathol. 152: 871-877.
42. Pedersen, W.A., Culmsee, C., Ziegler, D., Herman, J.P., and Mattson, M.P. 1999. Aberrant stress response associated with severe hypoglycemia in a transgenic mouse model of Alzheimer's disease. J. Mol. Neurosci. 13: 159-165.
43. Phillips, R.G. and LeDoux, J.E. 1992. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav. Neurosci. 106: 274-285.
44. -, 1994. Lesions of the dorsal hippocampal formation interfere with background but not foreground contextual fear conditioning. Learn. Mem. 1: 34-44
45. Price, D.L., Tanzi, R.E., Borchelt, D.R., and Sisodia, S.S. 1998. Alzheimer's disease: Genetic studies and transgenic models. Ann. Rev. Genet. 32: 461-493.
46. Raber, J., Wong, D., Yu, G.-Q., Buttini, M., Mahley, R., Pitas, R.E., and Mucke, L. 2000. Apolipoprotein E and cognitive performance. Nature 404: 352-354.
47. Rescorla, R.A. and Wagner, A.R. 1972 A theory of Pavlovian conditioning: Variations in the effectiveness of reinforcement and nonreinforcement. In Classical conditioning II: Current research and theory (eds. A.H. Black and W.F. Prokasy), pp. 64-99. Appleton-Century-Crofts, New York.
48. Richmond, M.A., Yee, B.K., Pouzet, B., Veenman, L., Rawlins, J.N., Feldon, J., and Bannerman, D.M. 1999. Dissociating context and space within the hippocampus: Effects of complete, dorsal, and ventral excitotoxic hippocampal lesions on conditioned freezing and spatial learning. Behav. Neurosci. 113: 1189-1203.
49. Scherder, E., Bouma, A., Borkent, M., and Rahman, O. 1999. Alzheimer patients report less pain intensity and pain affect than non-demented elderly. Psychiatry 62: 265-272.
50. Scott, S.A., DeKosky, S.T., and Scheff, S.W. 1991. Volumetric atrophy of the amygdala in Alzheimer's disease: Quantitative and serial reconstruction. Neurology 41: 351-356.
51. Scott, S.A., DeKosky, S.T., Sparks, D.L., Knox, C.A., and Scheff, S.W. 1992. Amygdala cell loss and atrophy in Alzheimer's disease. Ann. Neurol. 32: 555-563.
52. Selkoe, D.J. 1998. The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol. 8: 447-453.
53. -, 2000. The origins of Alzheimer disease: A is for amyloid. J. Am. Med. Assoc. 283: 1615-1617
54. -, 2001. Alzheimer's disease-Genotypes, phenotype, and treatments. Science 275: 630-631.
55. Smith, M.A., Hirai, K., Hsiao, K., Pappolla, M.A., Harris, P.L., Siedlak, S.L., Tabaton, M., and Perry, G. 1998. Amyloid-β deposition in Alzheimer transgenic mice is associated with oxidative stress. J. Neurochem. 70: 2212-2215.
56. Steinhilb, M.L., Turner, R.S., and Gaut, J.R. 2001. The protease inhibitor, MG132, blocks maturation of the amyloid precursor protein Swedish mutant preventing cleavage by β-secretase. J. Biol. Chem. 276: 4476-4484.
57. Stéphan, A., Laroche, S., and Davis, S. 2001. Generation of aggregated β-amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits. J. Neurosci. 21: 5703-5714.
58. Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.H., Mistl, C., Rothacher, S., Ledermann, B., Burki, K., Frey, P., Paganetti, P.A., et al. 1997. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl. Acad. Sci. 94: 13287-13292.
59. Takahashi, M., Dore, S., Ferris, C.D., Tomita, T., Sawa, A., Wolosker, H., Borchelt, D.R., Iwatsubo, T., Kim, S.H., Thinakaran, G., et al. 2000. Amyloid precursor proteins inhibit heme oxygenase activity and augment neurotoxicity in Alzheimer's disease. Neuron 28: 461-473.
60. Terai, K., Iwai, A., Tasaki, Y., Watanabe, T., Miyata, K., and Yamaguchi, T. 2001. β-Amyloid deposits in transgenic mice expressing human β-amyloid precursor protein have the same characteristics as those in Alzheimer's disease. Neuroscience 104: 299-310.
61. Tomidokoro, Y., Harigaya, Y., Matsubara, E., Ikeda, M., Kawarabayashi, T., Okamoto, K., and Shoji, M. 2000. Impaired neurotransmitter systems by Aβ amyloidosis in APPsw transgenic mice overexpressing amyloid β protein precursor. Neurosci. Lett. 292: 155-158.
62. Turner, R.S. 2001. Alzheimer's disease in man and transgenic mice: Females at higher risk. Am. J. Pathol. 158: 797-801.
63. Yamaguchi, F., Richards, S.J., Beyreuther, K., Salbaum, M., Carlson, G.A., and Dunnett, S.B. 1991. Transgenic mice for the amyloid precursor protein 695 isoform have impaired spatial memory. Neuroreport 2: 781-784.